P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
For decades the random 12-core biopsy has been the mainstay for diagnosing prostate cancer. Unfortunately, there is a slew of problems that comes with random biopsy, including misdiagnosis, infection, and …
BY MARK SCHOLZ,MD A Cancer that Can be Watched If someone tells you your cancer can be watched instead of treated, your initial reaction might be that they have no …
Elevated PSA does not point specifically to prostate cancer; it is only an indication that further investigation is necessary. Each year one million men are biopsied when they do not …
The process of Active Surveillance, the way we practice in Marina del Rey, is to perform a PSA blood test every three months and plot these results on a graph, …
IS IT POSSIBLE TO SKIP A BIOPSY? We’ve been talking a lot about the different types of biopsies – targeted vs random and all these new developments. But what’s really …
BY MARK SCHOLZ, MD Google keeps track of what is searched most frequently. Since prostate cancer is common, it’s hardly surprising that people who research aches or pains “down there” …
BY MARK SCHOLZ, MD There is a real danger that PSA screening will lead to overtreatment. The government, having studied this situation, has therefore recommended dropping PSA screening altogether. This proposal doesn’t …
BY MARK SCHOLZ, MD Prostate cancer is the most common form of cancer in men. While some types of prostate cancer are life-threatening, some types are not. Recent media reports …
BY MARK SCHOLZ, MD As men get older, they almost all develop enlargement of the prostate. Invariably, PSA rises as a result. PSA comes both from the prostate gland and …